T5 exonuclease-CAS12J fusion
T5 exonuclease-CAS12J fusion has been studied in 1 paper since 2026: none in people yet, 1 in cells; 1 in the past year. No study of it in people or animals has been published yet. The newest paper, Mar 13, 2026: “Characterization and engineering of highly efficient Cas12j genome editors”.
1 paper studies it1 findingUpdated
See all 1 papers on T5 exonuclease-CAS12J fusion
At a glance
The findings reach cells, none yet in people. 1 lab in 1 country.
- 1 lab in 1 country
- Funder: King Abdullah University of Science and Technology
- Cells1
What did studies of T5 exonuclease-CAS12J fusion find?
1Studies of T5 exonuclease-CAS12J fusion measured one outcome, genome editing efficiency.
Genome editing efficiency
upin mammalian cells1
1 study
Genome editing efficiency
upin mammalian cells1
T5 exonuclease-CAS12J fusion increases genome editing efficiency in mammalian cells across multiple mammalian cell types.
“We therefore engineered T5 exonuclease-Cas12j fusions, resulting in substantially enhanced genome-editing activity across multiple mammalian cell types”
Cellsacross multiple mammalian cell types
Characterization and engineering of highly efficient Cas12j genome editors
Trends in biotechnology